Oliver Wyman September 8, 2022
Brooks Conway and James Lucas

Providers interested in risk contracts with Medicare Advantage payers often struggle with the decision of whether to take on risk in Part D or whether to carve it out. If you are a provider considering such an arrangement, here are a few key questions to ask yourself prior to agreeing to take risk on Part D:

Do I have a large enough population?

The Centers for Medicare and Medicaid Services deems a Part D population credible at 56,000 member months (or 4,667 average members). This relatively large threshold is due to the low frequency and high severity of extremely costly specialty medications, which make Part...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare, Medicare Advantage, Provider
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
How Many Physicians Have Opted Out of the Medicare Program? - 2
MedPAC Members Vote to Recommend Pay Hikes for Physicians and Hospitals
Opinion: Former Trump health official: Medicare should cover Wegovy — but not negotiate its price
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.

Share This Article